trending Market Intelligence /marketintelligence/en/news-insights/trending/yysl3klfe0l4zvo-4aqtdw2 content esgSubNav
In This List

Destiny Pharma chairman to step down; replacement named

Blog

Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share


Destiny Pharma chairman to step down; replacement named

Destiny Pharma PLC said Nigel Rudd is stepping down as chairman and a member of its board Dec. 31.

Rudd will be replaced by Nick Rodgers, a nonexecutive director of Destiny Pharma, in the chairman role.

Brighton, U.K.-based Destiny Pharma develops and sells medicines for infectious diseases.